Gene · 6103
Papers1,847
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 1,847
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Construction of an Exudative Age-Related Macular Degeneration Diagnostic and Therapeutic Molecular Network Using Multi-Layer Network Analysis, a Fuzzy Logic Model, and Deep Learning Techniques: Are Retinal and Brain Neurodegenerative Disorders Related? | Pharmaceuticals (Basel) | 2023 | 38004422 | PubTator, text mining | PubMed |
| Strategies for developing sustainable communities in higher education institutions. | Sci Rep | 2023 | 37996505 | PubTator, text mining | PubMed |
| Deep Learning-Facilitated Study of the Rate of Change in Photoreceptor Outer Segment Metrics in RPGR-Related X-Linked Retinitis Pigmentosa. | Invest Ophthalmol Vis Sci | 2023 | 37988107 | PubTator, text mining | PubMed |
| Safety and Efficacy of Adeno-Associated Viral Gene Therapy in Patients With Retinal Degeneration: A Systematic Review and Meta-Analysis. | Transl Vis Sci Technol | 2023 | 37982768 | PubTator, text mining | PubMed |
| Application of Electrophysiology in Non-Macular Inherited Retinal Dystrophies. | J Clin Med | 2023 | 37959417 | PubTator, text mining | PubMed |
| Whole-Exome Sequencing of 21 Families: Candidate Genes for Early-Onset High Myopia. | Int J Mol Sci | 2023 | 37958660 | PubTator, text mining | PubMed |
| Clinical Manifestations and Genotype of Primary Ciliary Dyskinesia Diagnosed in Korea: Multicenter Study. | Allergy Asthma Immunol Res | 2023 | 37957793 | PubTator, text mining | PubMed |
| Exploring molecular mechanisms underlying the pathophysiological association between knee osteoarthritis and sarcopenia. | Osteoporos Sarcopenia | 2023 | 37941536 | PubTator, text mining | PubMed |
| Integrating properties and conditions to predict spray performance of alternative aviation fuel by ANN model. | Biotechnol Biofuels Bioprod | 2023 | 37941033 | PubTator, text mining | PubMed |
| Targeting the HIV reservoir: chimeric antigen receptor therapy for HIV cure. | Chin Med J (Engl) | 2023 | 37927030 | PubTator, text mining | PubMed |
| X -linked inheritance of primary ciliary dyskinesia and retinitis pigmentosa due to RPGR variant: A case report and literature review. | Respirol Case Rep | 2023 | 37915370 | PubTator, text mining | PubMed |
| Secretome analysis of breast cancer cells to identify potential target proteins of Ipomoea turpethum extract-loaded nanoparticles in the tumor microenvironment. | Front Cell Dev Biol | 2023 | 37900279 | PubTator, text mining | PubMed |
| Identification of the RPGR Gene Pathogenic Variants in a Cohort of Polish Male Patients with Retinitis Pigmentosa Phenotype. | Genes (Basel) | 2023 | 37895299 | PubTator, text mining | PubMed |
| Whole-Exome Sequencing of 24 Spanish Families: Candidate Genes for Non-Syndromic Pediatric Keratoconus. | Genes (Basel) | 2023 | 37895187 | PubTator, text mining | PubMed |
| The New Era of Therapeutic Strategies for the Treatment of Retinitis Pigmentosa: A Narrative Review of Pathomolecular Mechanisms for the Development of Cell-Based Therapies. | Biomedicines | 2023 | 37893030 | PubTator, text mining | PubMed |
| Retinal Dystrophy Associated With RLBP1 Retinitis Pigmentosa: A Five-Year Prospective Natural History Study. | Invest Ophthalmol Vis Sci | 2023 | 37883093 | PubTator, text mining | PubMed |
| A novel pathogenic splicing mutation of RPGR in a Chinese family with X-linked retinitis pigmentosa verified by minigene splicing assay. | Int J Ophthalmol | 2023 | 37854381 | PubTator, text mining | PubMed |
| Insights into the Role of Galectin-3 as a Diagnostic and Prognostic Biomarker of Atrial Fibrillation. | Dis Markers | 2023 | 37849915 | PubTator, text mining | PubMed |
| Study on a Novel Methodology for Developing the Skeletal Mechanism of RP-3 Aviation Kerosene. | ACS Omega | 2023 | 37841160 | PubTator, text mining | PubMed |
| Molecular Basis and Natural History of Medullary Thyroid Cancer: It is (Almost) All in the RET. | Cancers (Basel) | 2023 | 37835559 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6103/papers?page=10